JP2018504915A5 - - Google Patents

Download PDF

Info

Publication number
JP2018504915A5
JP2018504915A5 JP2017541256A JP2017541256A JP2018504915A5 JP 2018504915 A5 JP2018504915 A5 JP 2018504915A5 JP 2017541256 A JP2017541256 A JP 2017541256A JP 2017541256 A JP2017541256 A JP 2017541256A JP 2018504915 A5 JP2018504915 A5 JP 2018504915A5
Authority
JP
Japan
Prior art keywords
hsa
mir
expression level
mirs
subject
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2017541256A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018504915A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/DK2016/050032 external-priority patent/WO2016127998A1/en
Publication of JP2018504915A publication Critical patent/JP2018504915A/ja
Publication of JP2018504915A5 publication Critical patent/JP2018504915A5/ja
Pending legal-status Critical Current

Links

JP2017541256A 2015-02-11 2016-02-05 尿中の前立腺癌の早期発見のためのmicroRNAに基づく方法 Pending JP2018504915A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DKPA201500079 2015-02-11
DKPA201500079 2015-02-11
DKPA201500825 2015-12-21
DKPA201500825 2015-12-21
PCT/DK2016/050032 WO2016127998A1 (en) 2015-02-11 2016-02-05 A microrna-based method for early detection of prostate cancer in urine samples

Publications (2)

Publication Number Publication Date
JP2018504915A JP2018504915A (ja) 2018-02-22
JP2018504915A5 true JP2018504915A5 (enExample) 2019-02-28

Family

ID=55435920

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017541256A Pending JP2018504915A (ja) 2015-02-11 2016-02-05 尿中の前立腺癌の早期発見のためのmicroRNAに基づく方法

Country Status (6)

Country Link
US (1) US10400288B2 (enExample)
EP (1) EP3256602B1 (enExample)
JP (1) JP2018504915A (enExample)
CA (1) CA2976577C (enExample)
ES (1) ES2749651T3 (enExample)
WO (1) WO2016127998A1 (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016134727A1 (en) 2015-02-27 2016-09-01 Exiqon A/S A microrna-based method for assessing the prognosis of a prostate cancer patient
WO2018049506A1 (en) * 2016-09-14 2018-03-22 Ontario Institute For Cancer Research (Oicr) Mirna prostate cancer marker
CN106834470A (zh) * 2017-02-17 2017-06-13 张灏 miRNA在制备癌症诊断试剂盒中的用途
WO2018159750A1 (ja) * 2017-03-02 2018-09-07 第一三共株式会社 オピオイド薬の治療有効性を予測するためのmicroRNAバイオマーカー
CN107488734B (zh) * 2017-10-10 2019-11-05 广州医科大学附属第二医院 miR-19a-3p在制备前列腺癌骨转移诊断试剂和治疗药物中的应用
CN107663541A (zh) * 2017-10-31 2018-02-06 温州医科大学 一种用于诊断原发性肝癌的特异性生物标志物及其筛选方法与应用
US20210147944A1 (en) * 2018-04-10 2021-05-20 Unity Health Toronto Methods for monitoring and treating prostate cancer
WO2019220759A1 (ja) * 2018-05-17 2019-11-21 Stemcell株式会社 がんの分析方法、がんの分析システム、プログラムおよびコンピュータ読み取り可能な記録媒体
CN108424962B (zh) * 2018-05-25 2021-08-03 中国人民解放军陆军军医大学 系膜增生性肾小球肾炎的miRNA检测标志物及其诊断试剂盒
CN109112109A (zh) * 2018-07-27 2019-01-01 浙江大学 一种骨髓间充质干细胞外泌体的改造方法
EP3699300A1 (en) * 2019-02-22 2020-08-26 Institut d'Investigació Biomèdica de Bellvitge (IDIBELL) Seminal mirnas as non-invasive biomarkers for the diagnosis and/or prognosis of prostate cancer
JP2022524382A (ja) 2019-03-15 2022-05-02 エムアイアール サイエンティフィック,エルエルシー 前立腺がんを予測するための方法およびその使用
EP3719144A1 (en) * 2019-04-05 2020-10-07 Fundación para la Investigación Biomédica del Hospital Universitario de la Paz (FIBHULP) Mir-151a-3p as an universal endogenous control for exosome cargo normalization
JP2020195314A (ja) * 2019-05-31 2020-12-10 医薬資源研究所株式会社 疾患・体質の分析方法、疾患・体質の分析システム、プログラムおよびコンピュータ読み取り可能な記録媒体
JP7660898B2 (ja) * 2019-09-09 2025-04-14 Craif株式会社 マイクロrnaを含む体液抽出物
CN111118165B (zh) * 2020-03-04 2023-04-07 朱伟 一种与前列腺癌辅助诊断相关的血清miRNA标志物及其应用
CN112094910B (zh) * 2020-09-25 2023-03-24 无锡市中医医院 一种用于前列腺癌患病风险评估的miRNA标志物
CN112795657A (zh) * 2021-03-22 2021-05-14 中国农业大学 miRNA在制备诊断或辅助诊断哺乳动物前列腺癌症产品中的应用
EP4317454A4 (en) * 2021-03-29 2025-02-19 Toray Industries, Inc. Method for detecting microrna in biological sample, composition of hydrochloride of neutral amino acid, and container
KR102550113B1 (ko) * 2021-05-28 2023-07-03 주식회사 시스바이오젠 전립선암 진단용 바이오마커 및 이의 용도
CN114045344B (zh) * 2021-12-09 2024-12-17 觅瑞(杭州)生物科技有限公司 前列腺癌诊断用尿液miRNA标志物、诊断试剂及试剂盒
ES2995178A1 (es) * 2023-07-31 2025-02-07 Servicio Andaluz De Salud Biomarcadores y método de diagnóstico de la diabetes monogénica en adultos jóvenes portadores de alelos HNF1A deletéreos

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8455199B2 (en) 2007-09-14 2013-06-04 The Ohio State University Research Foundation MicroRNA expression in human peripheral blood microvesicles and uses thereof
CA2762986C (en) 2009-05-22 2018-03-06 Asuragen, Inc. Mirna biomarkers of prostate disease
EP3118334A1 (en) 2009-11-04 2017-01-18 DiamiR, LLC Methods of using small rna from bodily fluids for diagnosis and monitoring of neurodegenerative diseases
EP2341145A1 (en) * 2009-12-30 2011-07-06 febit holding GmbH miRNA fingerprint in the diagnosis of diseases
CA2795776A1 (en) 2010-04-06 2011-10-13 Caris Life Sciences Luxembourg Holdings, S.A.R.L. Circulating biomarkers for disease
MX338883B (es) 2010-07-27 2016-05-04 Genomic Health Inc Metodo para usar expresion de gen para determinar el pronostico de cancer de prostata.
EP2771487A1 (en) * 2011-10-27 2014-09-03 Asuragen, INC. Mirnas as diagnostic biomarkers to distinguish benign from malignant thyroid tumors
US9944991B2 (en) 2012-11-02 2018-04-17 Dana-Farber Cancer Institute, Inc. Compositions and methods for diagnosis, prognosis and treatment of hematological malignancies
WO2014085906A1 (en) 2012-12-03 2014-06-12 St. Michael's Hospital Microrna biomarkers for prostate cancer
CA2834187A1 (en) * 2013-04-15 2014-10-15 Norgen Biotek Corporation Use of micrornas for screening and diagnosis of prostate cancer and benign prostatic hyperplasia
CN103882118A (zh) * 2014-02-13 2014-06-25 绍兴市人民医院 用于检测前列腺癌的miRNAs
KR102761162B1 (ko) * 2014-06-12 2025-02-03 국립연구개발법인 고쿠리츠간켄큐센터 전립선암 검출 키트 또는 디바이스 및 검출 방법
EP3000895A1 (en) 2014-09-26 2016-03-30 Integragen A method for predicting responsiveness to a treatment with an EGFR inhibitor
WO2016115312A1 (en) * 2015-01-14 2016-07-21 Ohio State Innovation Foundation Mirna-based predictive models for diagnosis and prognosis of prostate cancer
WO2016134727A1 (en) 2015-02-27 2016-09-01 Exiqon A/S A microrna-based method for assessing the prognosis of a prostate cancer patient

Similar Documents

Publication Publication Date Title
JP2018504915A5 (enExample)
EP3124625B1 (en) miRNA fingerprint in the diagnosis of prostate cancer
JP6342329B2 (ja) Egfr阻害剤による治療に対する応答性を予測するための方法
EP2438187A1 (en) miRNA FINGERPRINT IN THE DIAGNOSIS OF MULTIPLE SCLEROSIS
JP2018507692A (ja) マイクロrnaに基づく前立腺がん患者の予後評価方法
Puente et al. Novel potential predictive markers of sunitinib outcomes in long-term responders versus primary refractory patients with metastatic clear-cell renal cell carcinoma
CA2916848C (en) Detection of brain cancer
US10975435B2 (en) Kit and method for the diagnosis/prognosis of idiopathic scoliosis
US20140024554A1 (en) Complex sets of mirnas as non-invasive biomarkers for glioblastoma
ES2686631T3 (es) Determinaciones de cáncer de pulmón utilizando relaciones de miARN
WO2016046365A1 (en) A method for predicting responsiveness to a treatment with an egfr inhibitor
EP3529376A1 (en) Biomarkers of oral, pharyngeal and laryngeal cancers
EP2578696A1 (en) MiRNAs as non-invasive biomarkers for diagnosis
US20240254566A1 (en) Analysis method, kit, and detection device
CN111315897B (zh) 用于黑素瘤检测的方法
JP2018502570A (ja) 持続陽圧呼吸療法に対する応答を予測する方法
WO2012089772A2 (en) Complex set of mirnas as non-invasive biomarkers for prostate diseases
Class et al. Patent application title: miRNA FINGERPRINT IN THE DIAGNOSIS OF PROSTATE CANCER Inventors: Andreas Keller (Puettlingen, DE) Andreas Keller (Puettlingen, DE) Eckart Meese (Huetschenhausen, DE) Eckart Meese (Huetschenhausen, DE) Anne Borries (Heidelberg, DE) Anne Borries (Heidelberg, DE) Markus Beier (Weinheim, DE) Markus Beier (Weinheim, DE) Assignees: Comprehensive Biomarker Center GmbH